Behaviour Toxicology
The new fields of activity material medical and activity embryology investigate the result of specific hepatotoxic exposures in humans and animals on learning, memory, and activity characteristics. 3 vital categories of activity neurotoxicants are metals, solvents, and pesticides. The clearest knowledge on the hurtful effects of antenatal exposure to toxicants comes from the study of 2 metals, lead and mercury, and from epidemiologic investigations of the results of alcohol taken throughout maternity. The less complete knowledge is on the market for 2 alternative teams of agents, solvents and pesticides. What we tend to do to realize their effects on the vertebrate brain is convincing enough to form U.S.A. demand caution in their distribution.
- Insomia.
- sedation.
- Impaired Pyschomotor activity.
Related Conference of Behaviour Toxicology
8th International Conference on Global Toxicology and Risk Assessment
7th International Conference on Clinical Pharmacology and Toxicology
Behaviour Toxicology Conference Speakers
Recommended Sessions
- Analytical Toxicology
- Applied pharmacology
- Aquatic Toxicology
- Behaviour Toxicology
- Cardiovascular Pharmacology
- Clinical Pharmacological
- Eco-Toxicology
- Experimental and Toxicologic Pathology
- Food Safety and Environmental Toxicology
- Forensic Toxicology
- Genotoxicity
- Immuno Toxicology
- In Vitro Toxicology
- Industrial and Occupational Toxicology
- Medical and Clinical Toxicology
- Medical Development and Safety Testing
- Microbial Toxicology
- Nano toxicology
- Pharmaceutical Toxicology
- Pharmacology
- Pharmacology Testing
- Toxicology
- Toxicology and Risk Assessment
- Toxicology Applications
- Toxicology Testing
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Alternative Testing Methods and 3Rs in Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Carcinogenic Risk and Chemical-Induced Cancers - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Chemical Risk Assessment Frameworks - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Climate Change and Toxicological Risk - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Computational Toxicology and AI Applications - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Ecotoxicology and Aquatic System Contamination - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Endocrine Disrupting Chemicals and Public Health - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Environmental Toxicology and Ecosystem Impact - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Food Safety and Chemical Contaminants - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Forensic Toxicology and Chemical Poisoning - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Genetic Toxicology and DNA Damage Assessment - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Global Trends in Toxicology Research and Innovation - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Heavy Metals and Toxic Element Exposure - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Human Biomonitoring and Exposure Science - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Immunotoxicology and Hypersensitivity Reactions - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Industrial and Occupational Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Nanotoxicology and Engineered Nanomaterials - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neurotoxicology and Developmental Exposure - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pesticide Toxicology and Risk Management - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pharmaceutical Toxicology and Drug Safety - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Regulatory Toxicology and Global Policy Trends - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Risk Communication in Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicity of Consumer Products and Personal Care Items - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicogenomics and Systems Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicokinetics and Chemical Fate in the Body - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)